EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Vincamine Counteracts Gentamicin-Induced Parotid Gland Toxicity: Insights Into Antioxidant Defense, TRPC1/CHOP Modulation and Ferroptosis-Related Pathways

Alaa Abouelhamd, Nourhan Elpry Mahmoud Shehata, Sara Mohamed Naguib Abdel-Hafez, Azza A K El-Sheikh, Dalia H Abu-Baih

Frontiers in Bioscience-Landmark · 16.10.2026 · 31 (10)

DOI: 10.31083/fbl55517 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Bioscience-Landmark, online erschienen am 16.10.2026. Verfasst von Alaa Abouelhamd und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry and Molecular Biology, Faculty of Pharmacy, Deraya University, 61111 New Minia City, Minia, Egypt. Hauptthemen laut MEDLINE: Gentamicins, Ferroptosis, Transcription Factor CHOP, Antioxidants. Die Arbeit nennt 77 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Princess Nourah bint Abdulrahman University Researchers Supporting Project.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Gentamicin (GET) is a widely used antibiotic, but its administration can cause parotid gland toxicity. Vincamine (VIN), a purified alkaloid with antioxidant and cytoprotective properties, may exert protective effects against gentamicin-induced toxicity. This study investigated the involvement of ferroptosis in GET-induced parotid gland toxicity and evaluated the protective effects of VIN and its potential underlying mechanisms.

Methods

Adult male rats were divided into four groups: control, GET (100 mg/kg, i.p.), VIN (40 mg/kg, p.o.), and GET/VIN. Treatments were administered for 7 days. Parotid gland injury was evaluated by measuring serum lactate dehydrogenase (LDH) levels. Oxidative stress and cellular damage were assessed by measuring total antioxidant capacity (TAC), glutathione homeostasis (glutathione (GSH)/oxidized glutathione (GSSG)), and lipid peroxidation based on malondialdehyde (MDA) levels. Ferroptosis-related markers (glutathione peroxidase 4 (GPX4), solute carrier family 7 member 11 (SLC7A11), transferrin receptor 1 (TFR1), ferroportin 1 (FPN1), ferritin heavy chain 1 (FTH1) and Nrf2/HO-1 expression), were analyzed. Endoplasmic reticulum stress-related markers, including C/EBP homologous protein (CHOP), PERK, GRP78, and transient receptor potential canonical 1 (TRPC1), were also evaluated. Histopathological examinations were also performed.

Results

GET significantly increased LDH levels and oxidative stress and induced parotid tissue damage. VIN treatment markedly reduced LDH levels, and attenuated oxidative stress. These protective effects were associated with modulation of Nrf2/HO-1 signaling and ferroptosis-related markers, including GPX4 and SLC7A11. VIN treatment was also associated with reduced markers of endoplasmic reticulum stress (CHOP, GRP78 and PERK) as well as restored TRPC1.

Conclusions

VIN exerted protective effects against GET-induced parotid gland toxicity, accompanied by reduced oxidative stress and modulation of ferroptosis- and endoplasmic reticulum stress-related pathways. These findings suggest that VIN may have potential for further investigation as a protective agent against gentamicin-induced parotid gland injury.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

GentamicinsFerroptosisTranscription Factor CHOPAntioxidantsParotid GlandVinca AlkaloidsAnimalsMaleRatsOxidative StressEndoplasmic Reticulum Chaperone BiPLipid PeroxidationGlutathioneSignal TransductionAmino Acid Transport System y+

Stichwörter der Autor:innen

ferroptosisgentamicinparotid toxicityvincamine

Substanzen

GentamicinsTranscription Factor CHOPAntioxidantsEndoplasmic Reticulum Chaperone BiPDdit3 protein, ratGlutathioneVinca AlkaloidsAmino Acid Transport System y+

Autor:innen und Institutionen

  • Department of Biochemistry and Molecular Biology, Faculty of Pharmacy, Deraya University, 61111 New Minia City, Minia, Egypt.
  • Faculty of Pharmacy, Deraya University, 61111 New Minia City, Minia, Egypt.
  • Department of Histology and Cell Biology, Faculty of Medicine, Minia University, 61519 Minia, Egypt.
  • Basic Health Sciences Department, College of Medicine, Princess Nourah bint Abdulrahman University, 11671 Riyadh, Saudi Arabia.

Förderung

  • Princess Nourah bint Abdulrahman University Researchers Supporting Project

Zitieren

APA

Abouelhamd, A., Shehata, N. E. M., Abdel-Hafez, S. M. N., El-Sheikh, A. A. K., & Abu-Baih, D. H. (2026). Vincamine Counteracts Gentamicin-Induced Parotid Gland Toxicity: Insights Into Antioxidant Defense, TRPC1/CHOP Modulation and Ferroptosis-Related Pathways. Frontiers in Bioscience-Landmark, 31(10). https://doi.org/10.31083/fbl55517

Vancouver

Abouelhamd A, Shehata NEM, Abdel-Hafez SMN, El-Sheikh AAK, Abu-Baih DH. Vincamine Counteracts Gentamicin-Induced Parotid Gland Toxicity: Insights Into Antioxidant Defense, TRPC1/CHOP Modulation and Ferroptosis-Related Pathways. Frontiers in Bioscience-Landmark. 2026;31(10). doi:10.31083/fbl55517

BibTeX
@article{Abouelhamd2026,
  author = {Abouelhamd, Alaa and Shehata, Nourhan Elpry Mahmoud and Abdel-Hafez, Sara Mohamed Naguib and El-Sheikh, Azza A K and Abu-Baih, Dalia H},
  title = {Vincamine Counteracts Gentamicin-Induced Parotid Gland Toxicity: Insights Into Antioxidant Defense, TRPC1/CHOP Modulation and Ferroptosis-Related Pathways},
  journal = {Frontiers in Bioscience-Landmark},
  year = {2026},
  volume = {31},
  number = {10},
  doi = {10.31083/fbl55517}
}
Kostenlos starten →